Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01140 |
| Species: | Homo sapiens |
| Position : | chr2:85750614-85811383 |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 26979803 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | DU-145 |
| CVCL ID: | CVCL_0105 |
| Cell Type: | prostate carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Chromatin interaction assay, TF binding assay, Gene expression assay |
| High Throughput Method: | Capture 3C-seq, ChIP-seq, RNA-seq, SNP genotyping array |
| Low Throughput Method: | 3C-qPCR, RT-qPCR |
| Target gene : | USP39 |
| TF name : | AR; FOXA1; HOXB13; CTCF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01139 | chr2:85750614-85811383 | Prostate | prostate epithelial cell | -- |
| E_01141 | chr2:85750614-85811383 | Prostate | prostate epithelial cell | -- |
| E_01142 | chr2:85750614-85811383 | Prostate | prostate epithelial cell | -- |
| E_01143 | chr2:85750614-85811383 | Blood | lymphoblastoid cell | -- |
| E_01144 | chr2:85750614-85811383 | Blood | lymphoblastoid cell | -- |